{"id":50230,"date":"2014-11-14T10:46:18","date_gmt":"2014-11-14T10:46:18","guid":{"rendered":"http:\/\/mostafa.openonline.co.uk\/?guid=ebe4bd6a707a8fc5ca9033924a433122"},"modified":"2014-11-14T10:46:18","modified_gmt":"2014-11-14T10:46:18","slug":"news-story-acmd-recommends-ban-for-two-legal-highs-linked-to-deaths","status":"publish","type":"post","link":"https:\/\/mostafa.openonline.co.uk\/?p=50230","title":{"rendered":"News story: ACMD recommends ban for two legal highs linked to deaths"},"content":{"rendered":"<div class=\"govspeak\">\n<p>The stimulant compound drug 4,4\u2019-DMAR, which is also known by the street name Serotoni, has been linked to 37 deaths in the UK &#8211; mostly in Northern Ireland. It is usually bought in tablet or powder form, and samples have also shown it being mixed with other drugs such as mephedrone and synthetic cannabinoids.<\/p>\n<p>MT-45, a synthetic opioid, is not currently available in the UK; however, like other opioids it can suppress respiratory function and presents a potentially lethal hazard. Deaths in Europe and the United States have been connected to MT-45. Users have also experienced hearing loss, breathing problems and fallen into comas.  <\/p>\n<p>Both MT-45 and 4,4\u2019-DMAR have recently been subjected to  risk assessments by the European Monitoring Centre for Drugs and Drug Addiction.<\/p>\n<p>The Council is now recommending that both drugs should be permanently banned as Class A substances and that, as neither of these substances have any known legitimate medical use, they should be scheduled under Schedule 1 of the Misuse of Drugs Regulations. <\/p>\n<p>Professor Les Iversen, chair of the ACMD, said: <\/p>\n<blockquote>\n<p>4,4\u2019-DMAR is a lethal stimulant drug ,closely related to the banned substance Aminorex.<\/p>\n<p>We already know opioid use can lead to addiction, acquisitive crime, family disruption and loss of employment. These could all be potential consequences if MT-45 becomes widely used in the UK. The ACMD is recommending the control of MT-45 based on its potential to cause significant harm in the UK.<\/p>\n<p class=\"last-child\">Both of these substances pose serious dangers and we are advising they should be banned in the UK.<\/p>\n<\/blockquote>\n<p>The ACMD has today published both its reports on MT-45 and 4,4\u2019-DMAR, which will now be considered by the Home Office. <\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>TWO lethal \u2018legal highs\u2019 should be controlled as class A substances, recommends the Advisory Council on the Misuse of Drugs (ACMD).<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"_links":{"self":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/50230"}],"collection":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=50230"}],"version-history":[{"count":0,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/50230\/revisions"}],"wp:attachment":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=50230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=50230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=50230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}